Trial Information

Summary: Clinical trial to test a study vaccine for Meningococcal disease in healthy infants

The purpose of this study is to test the safety and immune (ability to fight infection) response to the study vaccine for Meningococcal disease when given to healthy infants beginning at two months of age.

Study drug and study procedures will be made available to you at no cost.

To qualify, your infant must be:

• 2 months old (55-89 days)

Your child will not qualify if they:

• Has previously received a meningococcal vaccine, D,T,P, IPV, OPV
• Have a history of asthma, anaphylactic shock, urticaria, or other allergic reaction after previous vaccinations
• Have HIV infection

If you would like to learn more about participating in this study, please send an e-mail message using the form below.